Journal of Chest Surgery

The Korean Society for Thoracic and Cardiovascular Surgery (대한심장혈관흉부외과학회)
권호 표지
DOI QR코드

DOI QR Code

Pleural Carcinoembryonic Antigen and Maximum Standardized Uptake Value as Predictive Indicators of Visceral Pleural Invasion in Clinical T1N0M0 Lung Adenocarcinoma

  • Hye Rim Na (Department of Thoracic and Cardiovascular Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea) ;
  • Seok Whan Moon (Department of Thoracic and Cardiovascular Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea) ;
  • Kyung Soo Kim (Department of Thoracic and Cardiovascular Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea) ;
  • Mi Hyoung Moon (Department of Thoracic and Cardiovascular Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea) ;
  • Kwanyong Hyun (Department of Thoracic and Cardiovascular Surgery, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea) ;
  • Seung Keun Yoon (Department of Thoracic and Cardiovascular Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea)
  • Received : 2023.07.25
  • Accepted : 2023.10.27
  • Published : 2024.01.05
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Visceral pleural invasion (VPI) is a poor prognostic factor that contributes to the upstaging of early lung cancers. However, the preoperative assessment of VPI presents challenges. This study was conducted to examine intraoperative pleural carcinoembryonic antigen (pCEA) level and maximum standardized uptake value (SUVmax) as predictive markers of VPI in patients with clinical T1N0M0 lung adenocarcinoma. Methods: A retrospective review was conducted of the medical records of 613 patients who underwent intraoperative pCEA sampling and lung resection for non-small cell lung cancer. Of these, 390 individuals with clinical stage I adenocarcinoma and tumors ≤30 mm were included. Based on computed tomography findings, these patients were divided into pleural contact (n=186) and non-pleural contact (n=204) groups. A receiver operating characteristic (ROC) curve was constructed to analyze the association between pCEA and SUVmax in relation to VPI. Additionally, logistic regression analysis was performed to evaluate risk factors for VPI in each group. Results: ROC curve analysis revealed that pCEA level greater than 2.565 ng/mL (area under the curve [AUC]=0.751) and SUVmax above 4.25 (AUC=0.801) were highly predictive of VPI in patients exhibiting pleural contact. Based on multivariable analysis, pCEA (odds ratio [OR], 3.00; 95% confidence interval [CI], 1.14-7.87; p=0.026) and SUVmax (OR, 5.25; 95% CI, 1.90-14.50; p=0.001) were significant risk factors for VPI in the pleural contact group. Conclusion: In patients with clinical stage I lung adenocarcinoma exhibiting pleural contact, pCEA and SUVmax are potential predictive indicators of VPI. These markers may be helpful in planning for lung cancer surgery.

Keywords

References

  1. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin 2022;72:7-33. https://doi.org/10.3322/caac.21708
  2. Saji H, Okada M, Tsuboi M, et al. Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial. Lancet 2022;399:1607-17. https://doi.org/10.1016/S0140-6736(21)02333-3
  3. Koike T, Koike T, Yoshiya K, Tsuchida M, Toyabe S. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer. J Thorac Cardiovasc Surg 2013;146:372-8. https://doi.org/10.1016/j.jtcvs.2013.02.057
  4. Jiang L, Liang W, Shen J, et al. The impact of visceral pleural invasion in node-negative non-small cell lung cancer: a systematic review and meta-analysis. Chest 2015;148:903-11. https://doi.org/10.1378/chest.14-2765
  5. Rami-Porta R, Bolejack V, Giroux DJ, et al. The IASLC lung cancer staging project: the new database to inform the eighth edition of the TNM classification of lung cancer. J Thorac Oncol 2014;9:1618-24. https://doi.org/10.1097/JTO.0000000000000334
  6. Travis WD, Brambilla E, Rami-Porta R, et al. Visceral pleural invasion: pathologic criteria and use of elastic stains: proposal for the 7th edition of the TNM classification for lung cancer. J Thorac Oncol 2008;3:1384-90. https://doi.org/10.1097/JTO.0b013e31818e0d9f
  7. Kim H, Goo JM, Kim YT, Park CM. CT-defined visceral pleural invasion in T1 lung adenocarcinoma: lack of relationship to disease-free survival. Radiology 2019;292:741-9. https://doi.org/10.1148/radiol.2019190297
  8. Shi J, Li F, Yang F, et al. The combination of computed tomography features and circulating tumor cells increases the surgical prediction of visceral pleural invasion in clinical T1N0M0 lung adenocarcinoma. Transl Lung Cancer Res 2021;10:4266-80. https://doi.org/10.21037/tlcr-21-896
  9. Yang S, Yang L, Teng L, et al. Visceral pleural invasion by pulmonary adenocarcinoma ≤3 cm: the pathological correlation with pleural signs on computed tomography. J Thorac Dis 2018;10:3992-9. https://doi.org/10.21037/jtd.2018.06.125
  10. Hsu JS, Han IT, Tsai TH, et al. Pleural tags on CT scans to predict visceral pleural invasion of non-small cell lung cancer that does not abut the pleura. Radiology 2016;279:590-6. https://doi.org/10.1148/radiol.2015151120
  11. Riquet M, Badoual C, Le Pimpec Barthes F, et al. Visceral pleura invasion and pleural lavage tumor cytology by lung cancer: a prospective appraisal. Ann Thorac Surg 2003;75:353-5. https://doi.org/10.1016/s0003-4975(02)04403-x
  12. Iizuka S, Kawase A, Oiwa H, Ema T, Shiiya N, Funai K. A risk scoring system for predicting visceral pleural invasion in non-small lung cancer patients. Gen Thorac Cardiovasc Surg 2019;67:876-9. https://doi.org/10.1007/s11748-019-01101-x
  13. Shimizu K, Yoshida J, Nagai K, et al. Visceral pleural invasion is an invasive and aggressive indicator of non-small cell lung cancer. J Thorac Cardiovasc Surg 2005;130:160-5. https://doi.org/10.1016/j.jtcvs.2004.11.021
  14. Tanaka T, Shinya T, Sato S, et al. Predicting pleural invasion using HRCT and 18F-FDG PET/CT in lung adenocarcinoma with pleural contact. Ann Nucl Med 2015;29:757-65. https://doi.org/10.1007/s12149-015-0999-x
  15. National Comprehensive Cancer Network. Non-small cell lung cancer [Internet]. National Comprehensive Cancer Network; 2023 [cited 2023 Sep 24]. Available from: https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf
  16. Chen Z, Jiang S, Li Z, Rao L, Zhang X. Clinical value of 18F-FDG PET/CT in prediction of visceral pleural invasion of subsolid nodule stage I lung adenocarcinoma. Acad Radiol 2020;27:1691-9. https://doi.org/10.1016/j.acra.2020.01.019
  17. Zhang A, Meng X, Yao Y, et al. Predictive value of 18 F-FDG PET/MRI for pleural invasion in solid and subsolid lung adenocarcinomas smaller than 3 cm. J Magn Reson Imaging 2023;57:1367-75. https://doi.org/10.1002/jmri.28422
  18. Grunnet M, Sorensen JB. Carcinoembryonic antigen (CEA) as tumor marker in ung cancer. Lung Cancer. 2012;76:138-43. https://doi.org/10.1016/j.lungcan.2011.11.012
  19. Feng M, Zhu J, Liang L, et al Diagnostic value of tumor markers for lung adenocarcinoma-associated malignant pleural effusion: a validation study and meta-analysis. Int J Clin Oncol 2017;22:283-90. https://doi.org/10.1007/s10147-016-1073-y
  20. Nguyen AH, Miller EJ, Wichman CS, Berim IG, Agrawal DK. Diagnostic value of tumor antigens in malignant pleural effusion: a meta-analysis. Transl Res 2015;166:432-9. https://doi.org/10.1016/j.trsl.2015.04.006
  21. Lee JH, Chang JH. Diagnostic utility of serum and pleural fluid carcinoembryonic antigen, neuron-specific enolase, and cytokeratin 19 fragments in patients with effusions from primary lung cancer. Chest 2005;128:2298-303. https://doi.org/10.1378/chest.128.4.2298
  22. Hsieh TC, Huang WW, Lai CL, Tsao SM, Su CC. Diagnostic value of tumor markers in lung adenocarcinoma-associated cytologically negative pleural effusions. Cancer Cytopathol 2013;121:483-8. https://doi.org/10.1002/cncy.21283
  23. Satoh Y, Sugai S, Uehara H, et al. Clinical impact of intraoperative detection of carcinoembryonic antigen mRNA in pleural lavage specimens from nonsmall cell lung cancer patients. Thorac Cardiovasc Surg 2012;60:533-40. https://doi.org/10.1055/s-0031-1298066